These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 2634800

  • 1. [The M-VEC chemotherapy of advanced bladder tumors].
    Kumanov Kh, Ormanov I, Tsvetkov M, Donovski L.
    Khirurgiia (Sofiia); 1989; 42(6):39-45. PubMed ID: 2634800
    [Abstract] [Full Text] [Related]

  • 2. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].
    Rassweiler J, Rüther U, Bäuerle K, Bub P, Jipp P, Eisenberger F.
    Urologe A; 1989 Jan; 28(1):25-30. PubMed ID: 2922897
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.
    J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
    [Abstract] [Full Text] [Related]

  • 4. [Adjuvant chemotherapy with biocisplatin, methotrexate and biocarbazine in advanced bladder tumors].
    Ormanov I, Kumanov Kh, Tsvetkov M.
    Khirurgiia (Sofiia); 1989 Jan; 42(6):45-8. PubMed ID: 2634801
    [Abstract] [Full Text] [Related]

  • 5. Phase I-II pilot study on the efficacy and tolerability of neoadjuvant chemotherapy (Rescue M-VEC) and preoperative radiation therapy for infiltrating bladder cancer: results of an 18-month follow-up.
    Voce S, Montanari F, Arnone S, Dal Pozzo C, Suprani G, Cerullo G, Fornarola V.
    Arch Esp Urol; 1992 Jun; 45(5):491-8. PubMed ID: 1510485
    [Abstract] [Full Text] [Related]

  • 6. [Cases of the regression of advanced bladder tumors (T2-T4) after the use of chemotherapy].
    Kumanov Kh, Ormanov I, Tsvetkov M, Donovski L, Panchev P.
    Khirurgiia (Sofiia); 1990 Jun; 43(1):87-93. PubMed ID: 2395293
    [Abstract] [Full Text] [Related]

  • 7. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).
    Lehmann J, Retz M, Wiemers C, Beck J, Thüroff J, Weining C, Albers P, Frohneberg D, Becker T, Funke PJ, Walz P, Langbein S, Reiher F, Schiller M, Miller K, Roth S, Kälble T, Sternberg D, Wellek S, Stöckle M, AUO-AB 05/95.
    J Clin Oncol; 2005 Aug 01; 23(22):4963-74. PubMed ID: 15939920
    [Abstract] [Full Text] [Related]

  • 8. [The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder].
    Stöckle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.
    Ann Urol (Paris); 1993 Aug 01; 27(1):51-7. PubMed ID: 7682388
    [Abstract] [Full Text] [Related]

  • 9. [Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience].
    González Enguita C, Caro Cebrián C, Roncalés Badal A, Gil Sanz MJ, Martínez Bengoechea J, Rioja Sanz LA.
    Arch Esp Urol; 1990 Aug 01; 43 Suppl 2():197-204. PubMed ID: 2096779
    [Abstract] [Full Text] [Related]

  • 10. [Neoadjuvant chemotherapy with MVC (methotrexate, vinblastine, cisplatin)in the treatment of infiltrating transitional carcinoma of the bladder].
    Campo B, Torelli T, Leidi GL, Corrada P, Bacchioni AM, Ordesi G, Zanitzer L.
    Arch Ital Urol Nefrol Androl; 1990 Jun 01; 62(2):237-42. PubMed ID: 2142807
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 12. Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
    Tsai YS, Tzai TS, Chow NH.
    Urol Int; 2007 Sep 01; 79(3):210-6. PubMed ID: 17940352
    [Abstract] [Full Text] [Related]

  • 13. Quality of life in patients with advanced bladder cancer treated by tumorectomy and systemic adjuvant polychemotherapy (M-VAC). Our experience in 14 cases.
    Valente R, Marini F, Signori GB, Martino F.
    Arch Esp Urol; 1989 Sep 01; 42(1):87-9. PubMed ID: 2712609
    [Abstract] [Full Text] [Related]

  • 14. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.
    Arch Esp Urol; 1997 Jun 01; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [Abstract] [Full Text] [Related]

  • 15. [Intra-arterial chemotherapy for locally advanced bladder cancer].
    Aota Y, Yoshida K.
    Hinyokika Kiyo; 1999 Feb 01; 45(2):149-53. PubMed ID: 10212791
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Neoadjuvant chemotherapy of locally advanced tumors of the bladder: preliminary experience].
    Ruoppolo M, Bellorofonte C, Gritti A, Gozo M, Ferri PM, Tura M, Zaatar C, Tiraboschi B, Morosini D, Dell'Acqua S.
    Arch Ital Urol Nefrol Androl; 1990 Jun 01; 62(2):243-8. PubMed ID: 2142808
    [Abstract] [Full Text] [Related]

  • 18. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
    Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, Macaulay V, Munro N, Douglas D, Kilbey N, Protheroe A, Chester JD.
    Cancer; 2012 Aug 15; 118(16):3920-7. PubMed ID: 22614698
    [Abstract] [Full Text] [Related]

  • 19. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A, Gotoh A, Hara I, Gohji K, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Hamami G, Itani A.
    Gan To Kagaku Ryoho; 1990 Sep 15; 17(9):1909-15. PubMed ID: 2393308
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.